Clinical Trial Update: Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial assessed the combination of everolimus with gefitinib in patients with progressive glioblastoma and progressive metastatic prostate cancer; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Prostate Cancer

Drugs mentioned

• Afinitor (everolimus)
• Iressa (gefitinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors, Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-01-20